Loading…
Unicycive Therapeutics, Inc. is projected to rise to $8.92 by 2027, a +71% move from its current price of $5.21. UNCY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.92 | $5.21 | $5.53 | +0.08% |
| Jul 14 | $4.81 | $5.22 | $5.67 | +0.16% |
| Jul 15 | $4.72 | $5.22 | $5.78 | +0.25% |
| Jul 16 | $4.65 | $5.23 | $5.87 | +0.33% |
| Jul 17 | $4.59 | $5.23 | $5.96 | +0.41% |
| Jul 18 | $4.54 | $5.24 | $6.04 | +0.49% |
| Jul 19 | $4.49 | $5.24 | $6.11 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.49 | $5.24 | $6.11 | +0.58% |
| Week 2 | $4.24 | $5.27 | $6.55 | +1.15% |
| Week 3 | $4.06 | $5.30 | $6.92 | +1.74% |
| Week 4 | $3.92 | $5.33 | $7.26 | +2.32% |
| Week 5 | $3.80 | $5.36 | $7.57 | +2.91% |
| Week 6 | $3.70 | $5.39 | $7.87 | +3.50% |
| Week 7 | $3.61 | $5.42 | $8.15 | +4.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States.
Unicycive Therapeutics trades under the symbol UNCY and currently has a price of $5.26.
The asset has a market cap of $144.09M and is ranked 4043.
The 30-day price range runs from $3.54 to $7.81, and the near-term technical picture shows sentiment NEUTRAL with RSI 40, SMA50 $7.28, and SMA200 $6.30. The forecast suggests a bullish price outlook in forecast years beyond 2026, with rising average prices and substantial ROIs by the end of the period.
A major floor 51.7% below — a decisive break under it would weaken the trend.
The nearest floor, 10.0% below — buyers have tended to step in here.
The nearest ceiling, 57.6% above — a clean break opens room to run.
A major ceiling 83.4% above — clearing it would confirm fresh momentum.
Key UNCY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UNCY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.34 | Sell | $5.39 | Sell |
| MA 10 | $5.72 | Sell | $5.77 | Sell |
| MA 20 | $6.62 | Sell | $6.30 | Sell |
| MA 50 | $7.24 | Sell | $6.83 | Sell |
| MA 100 | $7.03 | Sell | $6.84 | Sell |
| MA 200 | $6.30 | Sell | $6.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.73 | Neutral |
| Stoch RSI (14) | 22.05 | Neutral |
| CCI (20) | -88.94 | Neutral |
| Williams %R (14) | -85.23 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -35.04 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 14.77 | Buy |
| TRIX (15) | -0.79 | Sell |
| Awesome (5,34) | -1.56 | Sell |
| Ultimate (7,14,28) | 54.46 | Neutral |
| Momentum (10) | -3.00 | Sell |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 5.21 | Buy |
| ADX (14) | 17.54 | Neutral |
| ATR (14) | 0.41 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 stands at 40, with the 50-day simple moving average at $7.28 and the 200-day simple moving average at $6.30. This places the near-term momentum around a neutral zone as the price navigates the current range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.69 | $5.21 | $9.25 | 0% | Neutral | |
| $6.47 | $8.92 | $13.30 | +71% | Bullish | |
| $7.51 | $11.00 | $17.47 | +111% | Bullish | |
| $7.32 | $11.30 | $18.84 | +117% | Bullish | |
| $7.30 | $11.80 | $20.49 | +127% | Bullish | |
| $7.98 | $13.48 | $24.23 | +159% | Bullish | |
| $6.83 | $12.05 | $22.32 | +131% | Bullish | |
| $9.67 | $17.76 | $33.81 | +241% | Bullish | |
| $13.56 | $25.91 | $50.59 | +397% | Bullish | |
| $12.17 | $24.16 | $48.27 | +364% | Bullish | |
| $16.19 | $35.98 | $79.00 | +591% | Bullish | |
| $36.43 | $80.95 | $186.18 | +14.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.69 | $5.21 | $6.66 | +0.00% |
| August 2026 | $4.44 | $5.37 | $6.79 | +3.16% |
| September 2026 | $4.57 | $5.61 | $7.24 | +4.45% |
| October 2026 | $5.18 | $6.44 | $8.45 | +14.79% |
| November 2026 | $5.47 | $6.88 | $9.15 | +6.71% |
| December 2026 | $5.41 | $6.87 | $9.25 | -0.16% |
Click any year to see its month-by-month UNCY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect UNCY to range from $4.69 to $9.25 through 2026. The $5.21 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The UNCY price prediction for 2027 points to an average of $8.92 (low $6.47, high $13.30) — a potential gain of +71% on today's $5.21. Buyers look set to stay in control over this stretch.
In 2028, UNCY is projected to trade between $7.51 and $17.47, averaging $11.00 — a potential gain of +111% from today's $5.21. That is up +23% on the projected 2027 average. Momentum favours further upside here.
Unicycive Therapeutics, Inc.'s 2029 outlook centres on $11.30, within a $7.32 to $18.84 range. That is up +3% on the projected 2028 average. That marks a +117% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, UNCY could reach as high as $20.49, with a base case around $11.80 and support toward $7.30 — roughly +127% from $5.21. Momentum favours further upside here.
Expect UNCY to range from $7.98 to $24.23 through 2031. The $13.48 average target implies a +159% move from current prices. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The UNCY price prediction for 2032 points to an average of $12.05 (low $6.83, high $22.32) — a potential gain of +131% on today's $5.21. Momentum favours further upside here.
In 2033, UNCY is projected to trade between $9.67 and $33.81, averaging $17.76 — a potential gain of +241% from today's $5.21. That is up +47% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Unicycive Therapeutics, Inc.'s 2034 outlook centres on $25.91, within a $13.56 to $50.59 range. That is up +46% on the projected 2033 average. That marks a +397% change versus current levels. Momentum favours further upside here.
By 2035, UNCY could reach as high as $48.27, with a base case around $24.16 and support toward $12.17 — roughly +364% from $5.21. Buyers look set to stay in control over this stretch.
Expect UNCY to range from $16.19 to $79.00 through 2040. The $35.98 average target implies a +591% move from current prices. That is up +49% on the projected 2035 average. Momentum favours further upside here.
The UNCY price prediction for 2050 points to an average of $80.95 (low $36.43, high $186.18) — a potential gain of +14.5x on today's $5.21. Buyers look set to stay in control over this stretch.
Investing $1,000 in UNCY today (≈ 191.93858 UNCY) could be worth
$15,537.32
+$14,537.32 (+1454%) by 2050 · US Dollar
Based on the average projected UNCY price of $80.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UNCYwould be worth at today's price.
$1,000 invested in UNCY on Jul 10, 2025 (≈ 190.47619 UNCY) would be worth
$992.38
-$7.62 (-0.8%) today · 0.99× · US Dollar
Based on a UNCY entry price of $5.25 vs. today's $5.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.73 | $909.25 | -9.1% |
| 1 month ago | $7.69 | $677.5 | -32.2% |
| 3 months ago | $6.63 | $785.82 | -21.4% |
| 6 months ago | $5.87 | $887.56 | -11.2% |
| 1 year ago | $5.25 | $992.38 | -0.8% |
| All time (5.0y) ago | $58.5 | $89.06 | -91.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UNCY forecast.
Our base-case forecast reaches $10.00 around 2028.
Implied market cap at $10.00: $273.93M
The multi-year forecast shows a bullish trajectory from 2027 onward, with rising averages and increasing ROI. In 2026 the min price is $4.69, the avg is $5.26, and the max is $9.38, with ROI at 0 and sentiment NEUTRAL. By 2027 the avg rises to $9.09 and ROI to 72.7% with a BULLISH signal, and 2028 carries an avg of $11.18 with ROI 112.6% (BULLISH).
2029 shows an avg of $11.55 and ROI 119.6% (BULLISH), and 2030 an avg of $12.14 and ROI 130.7% (BULLISH).
The growth continues in 2031 with an avg of $13.86 and ROI 163.5%, 2032 with an avg of $12.50 and ROI 137.7%, and 2033 with an avg of $18.59 and ROI 253.5%. The momentum remains strong into 2034 (avg $27.01, ROI 413.4%) and 2035 (avg $25.16, ROI 378.4%), all marked as BULLISH.
Towards 2040, the avg price is projected at $38.08 with ROI 623.9%, and by 2050 the avg is $85.81 with ROI 1531.4%, while the max in 2050 reaches $197.36. These figures indicate substantial upside potential, albeit as estimates subject to market conditions.
Tap a question to reveal the answer.
2030 forecast: min $7.50, avg $12.14, max $21.07, ROI 130.7%, sentiment BULLISH.
The forecast shows a bullish sentiment from 2027 onward with rising averages and ROIs: 2027 avg $9.09 (ROI 72.7%), 2028 avg $11.18 (ROI 112.6%), 2029 avg $11.55 (ROI 119.6%), and 2030 avg $12.14 (ROI 130.7%).
Yes. The 2050 max price is $197.36, which exceeds $100.
The current price is $5.26.
The 30-day range is from $3.54 to $7.81.
Unicycive Therapeutics, Inc. Community Discussion
0Share your Unicycive Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.